Pharmaceutical

NImmune and BioTherapeutics partner on precision medicine development

NImmune Biopharma and BioTherapeutics have partnered to develop new precision medicines in the field of inflammation and immunology.

Sep 8, 2024 - 04:00
NImmune and BioTherapeutics partner on precision medicine development
NImmune Biopharma and BioTherapeutics have partnered to develop new precision medicines in the field of inflammation and immunology.
Read the original article

Tags:

Previous Article

FDA grants ODD to Abdera’s neuroendocrine carcinoma treatment

Next Article

Evotec partners X-Chem for tech-enabled drug discovery

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Listen: Cancer drug shortages should be causing more outrage

Opinion: Listen: Cancer drug shortages should be causin...

Jun 28, 2023

Leprosy potentially endemic in Central Florida

Leprosy potentially endemic in Central Florida

Aug 16, 2023

Direct oral anticoagulants’ positive effects on cancer-associated VTE

Direct oral anticoagulants’ positive effects on cancer-...

Sep 5, 2023